Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.61
Delayed Data
As of 4:00pm ET
 +0.13 / +2.37%
Today’s Change
4.39
Today|||52-Week Range
9.02
-28.99%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +24.78% increase from the last price of 5.61.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Merrimack Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$98.0M
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -53.62%
 
 
 
 
 
Growthannually 2.51%
 
 
 
 
 
 

Sales

Growthquarterly 249.15%
 
 
 
 
 
 
Growthannually 48.24%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.